Organ and Metabolic Complications: Bleeding Disorders in Renal Failure

  • Vilma E. Quijada
  • Robert M. Lindsay
  • James F. Winchester


Coagulation abnormalities associated with renal diseases, are seen in chronic and acute renal failure, but also in nephrotic syndrome, glomerulonephritis, urogenital neoplasms, and renal transplantation. In this chapter we will discuss, specifically, uremia and acute renal failure, including disseminated intravascular coagulation, since the latter two conditions are often inextricably linked. For causes of, and manifestations of, bleeding/thrombosis in nephrotic syndrome, nephritis, genito-unnary cancer and transplantation the reader is referred to a recent review (1). Normal hemostasis is outlined in Figure I


Peritoneal Dialysis Acute Renal Failure Hemolytic Uremic Syndrome Subdural Hematoma Bleeding Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Quijada VE, Winchester JF: Renal Disease and Urology. in Management of Bleeding Disorders in Surgical Practice, edited by Forbes CD, Cuschieri A, Oxford, Blackwell Scientific Publications Ltd, 1993, p 149Google Scholar
  2. 2.
    Bright R: Reports of Medical Cases Guy’s Hospital of London. Longman, Rees, Orme and Brown, London, 1827Google Scholar
  3. 3.
    Gafter U, Bessler H, Malachi T et al.: Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron 45: 207, 1987PubMedGoogle Scholar
  4. 4.
    Babcock RB, Dumper CW, Scharfman WB: Heparin induced immune thrombocytopenia. N Engl J Med 95: 237, 1976CrossRefGoogle Scholar
  5. 5.
    George, JN and Shattil, SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324: 27, 1991PubMedCrossRefGoogle Scholar
  6. 6.
    Di Minno G, Martinez J, McKean ML et al.: Platelet dysfunction in uremia. Multifaceted defect corrected by dialysis. Am J Med 79: 552, 1985PubMedCrossRefGoogle Scholar
  7. 7.
    Winchester JF, Forbes CD, Lang S et al.: Platelet function regulating agents — experimental data relevant to renal disease. in Thromboembolism: A New Approach to Therapy. edited by Mitchell JRA, Domenet JGI, London, Academic Press, 1977, p 84Google Scholar
  8. 8.
    Lindsay RM, Friesen M, Koens F et al.: Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335, 1976PubMedGoogle Scholar
  9. 9.
    Rabiner SF, Molinas F: The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49: 346, 1970PubMedCrossRefGoogle Scholar
  10. 10.
    Weiss, HJ: Acquired qualitative platelet disorders. in Hematology, edited by Williams WJ, Beutler E, Erslev, AJ et al., New York, McGraw-Hill, 1972, p 177Google Scholar
  11. 11.
    Eknoyan G, Wacksman SJ, Gluek HI et al.: Platelet function in renal failure. N Engl J Med 280: 677, 1969PubMedCrossRefGoogle Scholar
  12. 12.
    Bazilinski N, Shaykh M. Dunea G et al.: Inhibition of platelet function by uremic middle molecules. Nephron 40: 423, 1985PubMedGoogle Scholar
  13. 13.
    Remuzzi G. Benigni A, Dodesini P et al.: Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. J Clin Invest 71: 762, 1983PubMedGoogle Scholar
  14. 14.
    Remuzzi G: Bleeding disorders in uraemia: pathophysiology and treatment. Adv Nephrol 18: 171, 1989Google Scholar
  15. 15.
    Gawaz MP, Ward RA: Effects of hemodialysis on platelet-derived thrombospondin (TSP). Abstr Am Soc Nephrol 398, 1990Google Scholar
  16. 16.
    Knudsen F, Dyerberg J: Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. Scand J Clin Lab Invest 45: 341, 1985PubMedCrossRefGoogle Scholar
  17. 17.
    Ware JA, Clark BA, Smith M et al.: Abnormalities in cytoplasmic Ca2+ in platelets from patients with uremia. Blood 73: 172, 1989PubMedGoogle Scholar
  18. 18.
    Steiner RW, Coggins C, Carvalho A: Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol 7: 107, 1979PubMedCrossRefGoogle Scholar
  19. 19.
    Moosa A, Greaves M, Brown CB, MacNeil S: Elevated platelet-free calcium in uremia. Br J Haematol 74: 300, 1990PubMedGoogle Scholar
  20. 20.
    Cases A, Escolar G, Reverter JC et al.: Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int 42: 668, 1992PubMedCrossRefGoogle Scholar
  21. 21.
    Livio M, Gotti E, Marchesi D: Uraemic bleeding. Role of anaemia and beneficial effect of red cell transfusion. Lancet 2: 1013, 1982PubMedCrossRefGoogle Scholar
  22. 22.
    Roger SD, Piper J, Tucker B, Raine AE, Baker LR, Kovacs IB: Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry. Nephron 62: 422, 1992PubMedGoogle Scholar
  23. 23.
    Di Paolo N, Capotondo L, Rossi P et al.: Bleeding tendency of chronic uraemia improved by vascular factor. Nephron 52: 268, 1989PubMedGoogle Scholar
  24. 24.
    Remuzzi G, Cavenaghi AE, Mecca G et al.: Prostacyclinlike activity and bleeding in renal failure. Lancet 2: 1195, 1977PubMedCrossRefGoogle Scholar
  25. 25.
    Slazus W: Increased platelet production of prostacyclin after injury to the microvasculature in uraemic platelets. 5 Afr Med J 81: 315, 1992Google Scholar
  26. 26.
    Zoja C, Vigano G, Bergamelli A, Benigni A, de Gaetano G, Remuzzi G: Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: effects of conjugated estrogens. J Lab Clin Med 112: 380, 1988PubMedGoogle Scholar
  27. 27.
    Takano S, Kimura S, Ohdama S, Aoki N: Plasma thrombomodulin in health and disease. Blood 16: 2024, 1990Google Scholar
  28. 28.
    Remuzzi G, Perico N, Zoja C, Coma D, Macconi D, Vigano G: Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 86: 1768, 1990PubMedGoogle Scholar
  29. 29.
    Noris M, Begnini A, Boccardo P et al.: Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 44: 445, 1993PubMedCrossRefGoogle Scholar
  30. 30.
    Zoja C, Noris M, Coma D et al.: L-arginine the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 65: 479, 1991PubMedGoogle Scholar
  31. 31.
    Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by Factor VIII-von Willebrand factor bound to the subendothelium. Nature (London) 279: 636, 1979CrossRefGoogle Scholar
  32. 32.
    Kazatchkine N, Sultan V, Caen JP et al.: Bleeding in uremia: a possible cause. Br Med J 2: 612, 1976PubMedCrossRefGoogle Scholar
  33. 33.
    Howard MA, Whitworth JA, Hendrix L et al.: Abnormal Factor VIII in chronic renal failure. Med J Aust 1: 148, 1979PubMedGoogle Scholar
  34. 34.
    Janson PA, Jubelirer ST, Weinstein MJ: Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318, 1980PubMedCrossRefGoogle Scholar
  35. 35.
    Mannuci PM, Remuzzi G, Pusineri F et al.: Deamino 8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8, 1983CrossRefGoogle Scholar
  36. 36.
    Sorensen PJ, Knudsen F, Nielsen A et al.: Protein C assays in uremia. Thromb Res 54: 301, 1989PubMedCrossRefGoogle Scholar
  37. 37.
    Knudsen F, Sorensen PJ, Hoj A et al.: Inhibitors of coagulation in terminal renal failure and hemodialysis. Nephron 49:335, 1988PubMedGoogle Scholar
  38. 38.
    Faioni EM, Franchi F, Krachmalnicoff A et al.: Low levels of the anticoagulant activity of protein c in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma. Thromb Haemost 66: 420, 1991PubMedGoogle Scholar
  39. 39.
    Quereda C, Pardo A, Lamas S et al.: Lupus-like in vitro anticoagulant activity in end-stage renal disease. Nephron 49: 39, 1988PubMedGoogle Scholar
  40. 40.
    D’Agati V, Kunis Ch, Williams G: Anticardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1: 777, 1990PubMedGoogle Scholar
  41. 41.
    Brand, TP, Jesperson, J, Sorensen, LH: Antithrombin III and platelets in hemodialysis patients. Nephron 28: 1, 1981Google Scholar
  42. 42.
    Allon M, Soffer O, Evatt B et al.: Protein S and C antigen levels in proteinuric patients. Am J Hematol 31: 96, 1989PubMedCrossRefGoogle Scholar
  43. 43.
    Bronner M, Pati M, Cunningham C et al.: Estrogenprogesterone therapy for bleeding gastrointestinal telangiectasis in chronic renal failure. An uncontrolled trial. Ann Intern Med 105: 371, 1986PubMedGoogle Scholar
  44. 44.
    Suki WN: Pericarditis. Kidney Int 33(Suppl 24): 10S, 1988Google Scholar
  45. 45.
    Maher JF, Schreiner GE: Hazards and complications of dialysis. N Engl J Med 272: 370, 1966Google Scholar
  46. 46.
    Bechar M, Lakke JP et al.: Subdural hematoma during long term hemodialysis. Arch Neurol 26: 513, 1972PubMedGoogle Scholar
  47. 47.
    Tietjen DP, Moore J Jr, Gouge, SF: Hemodialysis associated acute subdural hematoma Interim management with peritonea] dialysis. Am J Nephrol 7: 478, 1987PubMedGoogle Scholar
  48. 48.
    Ingelberg R: Non-surgical treatment of subdural hematoma in hemodialysis patients. Clin Neurol Neurosurg 91: 85, 1989CrossRefGoogle Scholar
  49. 49.
    Fernandez F, Goudable C, Su P et al.: Low hematocrit and prolonged bleeding time in uraemic patients: Effect of red cell transfusions. Br J Haematol 59: 139, 1985PubMedGoogle Scholar
  50. 50.
    Moia, M, Mannucci, PM, Vizzotto, I et al.: Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2: 1227, 1987PubMedCrossRefGoogle Scholar
  51. 51.
    Huraib S, al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H: The effects of recombinant human erythropoietin (sHuEpo) on the hemostatic system in chronic hemodialysis patients. Clin Nephrol 36: 252, 1991PubMedGoogle Scholar
  52. 52.
    Taylor JE, Belch JJ, McLaren M, Henderson IS, Stewart WK: Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients. Kidney Int 44: 182, 1993PubMedCrossRefGoogle Scholar
  53. 53.
    Taylor JE, Henderson IS, Stewart WK, Belch JJ: Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. Lancet 2: 1361, 1990Google Scholar
  54. 54.
    Rabiner, SF, Drake, RF: Platelet function as an indicator of adequate dialysis. Kidney Int 7(Suppl 2): S144, 1975Google Scholar
  55. 55.
    Triulzi DJ, Blumberg N: Variability in response to cryoprecipitate treatment for hemostatic defects in uremia. Yale J Biol Med 63: 1, 1990PubMedGoogle Scholar
  56. 56.
    Ziegler ZR, Megaludis A, Fraley DS: Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia. Am J Hematol 39: 90, 1992CrossRefGoogle Scholar
  57. 57.
    Vigano GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G: Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 31: 32, 1989PubMedCrossRefGoogle Scholar
  58. 58.
    Liu Y, Kosfeld R, Marcum S: Treatment of uraemic bleeding with conjugated oestrogens. Lancet 2: 887, 1984PubMedCrossRefGoogle Scholar
  59. 59.
    Shemin D, Elnour M, Amarantes B, Abuelo JG, Chazan JA: Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure. Am J Med 89: 436, 1990PubMedCrossRefGoogle Scholar
  60. 60.
    Vigano G, Zoja C, Corna D et al.: 17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism. J Pharmacol Exp Ther 252: 344, 1990PubMedGoogle Scholar
  61. 61.
    Zoja C, Vigano, G, Corna, D et al.: Oral zeranol shortens the prolonged bleeding time of uremic rats. Kidney Int 38: 96, 1990PubMedCrossRefGoogle Scholar
  62. 62.
    Ryan KE, Lane DA, Flynn A et al.: Antithrombotic effect of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. Thromb Haemost 68: 563, 1992PubMedGoogle Scholar
  63. 63.
    Manian FA. Stone WJ, Alford RH: Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 12: 236, 1990PubMedGoogle Scholar
  64. 64.
    Steinman T, Lazarus JM: Organ system involvement in acute renal failure. in Acute Renal Failure, edited by Brenner BM, Lazarus JM, Philadelphia, Saunders, 1983, p 586Google Scholar
  65. 65.
    White DJ, Young F, McKendrick MW: Haemolytic uraemic syndrome in adults. Br Med J 296: 899, 1988Google Scholar
  66. 66.
    Kavi J, Wise R: Causes of the haemolytic uraemic syndrome. It might be verocytoxin produced by Escherichia coli. Br Med J 298: 65, 1989CrossRefGoogle Scholar
  67. 67.
    Kelton JG, Moore JC, Murphy WG: Studies investigating platelet aggregation and releases initiated by sera from patients with thrombotic thrombocytopenic purpura. Blood 69: 924, 1987PubMedGoogle Scholar
  68. 68.
    Walters M, Levin M, Smith C et al.: Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 33: 107, 1990CrossRefGoogle Scholar
  69. 69.
    Monteagudo J, Pereira A, Roig S et al.: Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic uremic syndrome. Am J Hematol 33: 46, 1990PubMedCrossRefGoogle Scholar
  70. 70.
    Chugh KS, Pal Y, Chakravarty RN et al.: Acute renal failure following poisonous snakebite. Am J Kidney Dis 4: 30, 1984PubMedGoogle Scholar
  71. 71.
    Stratta P, Canavese C, Goia L et al.: Clinical therapeutic correlations in consumption coagulopathy of obstetric acute renal failure. Clin Exp Obstet Gynecol 13: 43, 1986PubMedGoogle Scholar
  72. 72.
    Kanfer A: Coagulation and renal diseases. Proc Eur Dial Transplant Assoc 19: 703, 1982Google Scholar
  73. 73.
    Gotti E, Mecca G, Valentino C et al.: Renal biopsy in patients with acute renal failure and prolonged bleeding time. Lancet 2: 978, 1984PubMedCrossRefGoogle Scholar
  74. 74.
    McMurray SD, Luft FC, Maxwell DR et al.: Prevailing patterns and predictor variables in patients with acute jubular necrosis. Arch Intern Med 138: 950, 1978PubMedCrossRefGoogle Scholar
  75. 75.
    Kleinknecht D, Jungers P, Chanar, J et al.: Uremic and nonuremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 1: 190, 1972PubMedCrossRefGoogle Scholar
  76. 76.
    Larsson SO, Hedner U, Nilsson IM: On coagulation and fibrinolysis in acute renal insufficiency. Acta Med Scand 189: 443, 1971PubMedCrossRefGoogle Scholar
  77. 77.
    Kanfer A, Vandewalle A, Beaufils M et al.: Enhanced antiplasmin activity in acute renal failure. Br Med J 4: 195, 1975PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Vilma E. Quijada
    • 1
  • Robert M. Lindsay
    • 2
  • James F. Winchester
    • 1
  1. 1.Department of NephrologyGeorgetown University Medical CenterWashington, DCUSA
  2. 2.University of Western OntarioLondonCanada

Personalised recommendations